Trials / Completed
CompletedNCT01162603
Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)
Comparative Evaluation of Intraocular Pressure During the 24 Hour in Patients Affected by Primary Open-angle Glaucoma and Ocular Hypertension: Latanoprost 0.005% Versus Tafluprost 0.0015% Ophthalmic Solutions
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
* Main objective is to compare the ability of Latanoprost 0.005% preservative-added ophthalmic solution versus Tafluprost 0.0015% preservative-free ophthalmic solution, both given once a day at the evening, in reducing 24-hour intraocular pressure (IOP) in patients with primary open angle glaucoma (POAG) and/or ocular hypertension (OHT) at first diagnosis. First efficacy variable will be the difference between mean nocturnal IOP values after three months of treatment: nocturnal IOP is defined as the mean value between 2AM and 6AM measurements. * Secondary objectives will be the comparison between Latanoprost 0.005% and Tafluprost 0.0015% ophthalmic solution about: * Mean 24-hour IOP values after three months of treatment * IOP values at these time-points: 10AM (± 1 hour), 2PM (± 1 hour), 6PM (± 1 hour), 10PM (± 1 hour), 2AM (± 1 hour) and 6AM (± 1 hour) after three months of treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Goldmann and Perkins applanation tonometry | IOP values will be assessed by the means of Goldmann or Perkins applanation tonometry at the following time-points: 10AM (± 1 hour), 2PM (± 1 hour), 6PM (± 1 hour), 10PM (± 1 hour), 2AM (± 1 hour) and 6AM (± 1 hour) after three months of treatment |
| DRUG | TAFLUPROST 0.0015% EYEDROPS | Tafluprost 0.0015% preservative-free ophthalmic solution |
| DRUG | LATANOPROST 0.005% EYEDROPS | Latanoprost 0.005% preservative-added ophthalmic solution |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2010-07-14
- Last updated
- 2013-05-07
Locations
2 sites across 2 countries: Greece, Italy
Source: ClinicalTrials.gov record NCT01162603. Inclusion in this directory is not an endorsement.